Nothing seems to bother NASDAQ:PBIP, NASDAQ:USEG, NASDAQ:ELTK, NASDAQ:SVA

0
85

PRUDENTIAL BANCORP EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:PBIP)

HOW HAS PRUDENTIAL BANCORP’S STOCK BEEN IMPACTED BY THE PRESIDENTIAL ELECTION? (NASDAQ:PBIP)

Prudential Bancorp’s stock was trading at $11.89 on November 3rd, 2020 when the presidential election occured and Joe Biden was elected president. Since then, PBIP shares have increased by 8.2% and is now trading at $12.86.

U.S. ENERGY (NASDAQ:USEG) EARNINGS INFORMATION (NASDAQ:USEG)

U.S. Energy last posted its quarterly earnings data on August 14th, 2020. The energy company reported ($0.65) earnings per share (EPS) for the quarter. The company had revenue of $0.19 million for the quarter. U.S. Energy has generated $0.00 earnings per share over the last year. U.S. Energy has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, March 29th, 2021 based off prior year’s report dates.

HOW HAS U.S. ENERGY’S STOCK PRICE BEEN IMPACTED BY THE U.S. ELECTION? (NASDAQ:USEG)

U.S. Energy’s stock was trading at $4.05 on November 3rd, 2020 when the U.S. election occured and Joe Biden was elected president. Since then, USEG stock has decreased by 18.0% and is now trading at $3.32.

ELTEK EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:ELTK)

HOW HAS ELTEK’S STOCK BEEN IMPACTED BY THE U.S. PRESIDENTIAL ELECTION? (NASDAQ:ELTK)

Eltek’s stock was trading at $4.83 on November 3rd, 2020 when the U.S. presidential election occured and Joe Biden was elected president. Since then, ELTK shares have decreased by 5.0% and is now trading at $4.59.

SINOVAC BIOTECH (NASDAQ:SVA) EARNINGS INFORMATION (NASDAQ:SVA)

Sinovac Biotech last released its earnings results on August 28th, 2020. The biopharmaceutical company reported ($0.05) earnings per share for the quarter. The business had revenue of $52.33 million for the quarter. Sinovac Biotech has generated $0.00 earnings per share over the last year and currently has a price-to-earnings ratio of 46.2.

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN SINOVAC BIOTECH? (NASDAQ:SVA)

Wall Street analysts have given Sinovac Biotech a “N/A” rating, but there may be better short-term opportunities in the market. Some of MarketBeat’s winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sinovac Biotech wasn’t one of them. MarketBeat thinks these five stocks may be even better buys.